Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Dosing in Severe COVID-19 Pneumonia
NCT04263402Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Feb 2020
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection in COVID-19 pneumonia, sponsored by Tongji Hospital. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04263402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263402.